« All members

Roche Diagnostics and Diabetes UK

Type of organisation: Medical Technology & Diagnostics

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
As the UK leader in diagnostics solutions, we offer a uniquely broad and innovative portfolio of products to patients, physicians, researchers, hospitals, laboratories and universities.  We are proud of the many collaborative partnerships we have forged both in Diagnostics and Diabetes Care with the health system across Wales, bringing  our innovative solutions to help improve health outcomes of the population across the country. 
Our UK Diagnostics business, headquartered in Burgess Hill, West Sussex, employs over 600 highly skilled individuals working across the UK.  Roche contributes £7 million GDP to the Welsh economy through supply chain and employee spending.
The pandemic shone a light on the vital role Diagnostics plays in the health of every person and will continue to have an increasingly important role in the future of healthcare as genetic knowledge presents new and exciting opportunities. Our desire is to provide clinicians and patients with actionable health information – information that reduces the uncertainty in the medical decision making process, enabling them to choose between available alternatives to prevent or treat disease. 
Visit website

Phone:01444 256000

Location:Charles Avenue, Burgess Hill
West Sussex
RH15 9RY

Roche Diagnostics and Diabetes UK news articles

20 October 2022

Roche launches next generation of rapid antigen tests


Read more

1 April 2022

Harnessing digitalisation in point of care to deliver greater value


Read more

23 July 2021

Report calls for breakthrough diagnostics to be funded like new medicines


Read more